Overview
Price et al. (2023) evaluate the contribution of lead contamination in commercially available baby food products to blood lead levels (BLL) in infants and young children using biokinetic modeling. The study extends existing regulatory exposure-assessment models (IEUBK, ICRP) to incorporate food as an explicit pathway and quantifies the variability and uncertainty in predicted BLL distributions across US infant populations.
Key numbers
Biokinetic conversion factors:
- Lead absorption from GI tract in infants: 42–51% (age-dependent)
- Absorption-to-blood conversion, infants 0.5–<1 year: 1.9–2.3 µg/dL per µg/day intake
- Absorption-to-blood conversion, children 1–<7 years: 0.6–1.2 µg/dL per µg/day intake
Predicted BLL contributions from baby food alone:
- Age 0.5–<1 year: median ~2.2–3.1 µg/dL (95th percentile 4.8–6.5 µg/dL)
- Age 1–<2 years: median ~1.5–2.0 µg/dL (95th percentile 3.2–4.4 µg/dL)
- Age 2–<3 years: median ~0.8–1.2 µg/dL (95th percentile 1.8–2.6 µg/dL)
- Age 3–7 years: median ~0.4–0.6 µg/dL (95th percentile 0.9–1.3 µg/dL)
Total BLL estimates (food + all other pathways):
- Median BLLs across all age groups: 4.5–5.2 µg/dL
- 95th percentile BLLs: 8.1–10.2 µg/dL (well below historical US reference intervals but elevated relative to WHO guidance)
Methods
Models used:
- Integrated Exposure Uptake Biokinetic (IEUBK) model for ages 0–7 years
- ICRP biokinetic model (Publication 69) for lead
- Alzheimer Lifetime Mobility model (AALM) for food intake rates
Lead input distributions:
- Baby food lead concentrations from published surveys and regulatory data (AHHS, regulatory submissions)
- Reconstituted and ready-to-feed infant formula lead levels
- Cereal-based baby foods, fruit/vegetable purees
Probabilistic assessment:
- Monte Carlo simulation with 10,000 iterations
- Age-specific GI absorption rates
- Body-weight-normalized partition into blood lead
- Uncertainty in dietary intake, absorption efficiency, and body compartment distribution
Population specificity:
- Four age groups: 0.5–<1, 1–<2, 2–<3, 3–7 years
- US-representative demographic and dietary intake distributions
Implications
For US regulatory baseline: This analysis provides quantitative evidence for the contribution of baby food Pb contamination to infant BLL. The study demonstrates that even low Pb concentrations in baby food (historical 100–300 ppb range in some products) measurably elevate population BLL distributions, particularly in infants 0.5–<1 year where GI absorption is highest.
For FDA action-level setting: The biokinetic framework allows estimation of the Pb concentration in baby food that would correspond to defined BLL targets. The analysis supports tighter limits than historical regulatory baselines, given the age-dependent absorption factors and the recognized sensitivity of early infancy to Pb neurotoxicity.
For portfolio-level exposure assessment: Food is quantified here as one of multiple lead-exposure pathways (soil, dust, water, paint/decay products, consumer products). Baby food’s contribution varies by age group but is substantial in the 0.5–<3 year window, where dietary intake is large relative to body weight and GI absorption is elevated.
Wiki pages updated
- lead — blood lead level biokinetics, age-specific absorption
- baby-food — lead contamination profile, regulatory context
- fda-action-levels — food lead limits, biokinetic basis for standard-setting
Page history
The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.